Literature DB >> 25499006

Emergency Resuscitation of Patients Enrolled in the US Diaspirin Cross-linked Hemoglobin (DCLHb) Clinical Efficacy Trial.

Edward P Sloan1, Max Koenigsberg2, W Brad Weir3, James M Clark4, Robert O'Connor5, Michael Olinger6, Rita Cydulka7.   

Abstract

INTRODUCTION: Optimal emergent management of traumatic hemorrhagic shock patients requires a better understanding of treatment provided in the prehospital/Emergency Medical Services (EMS) and emergency department (ED) settings. Hypothesis/Problem Described in this research are the initial clinical status, airway management, fluid and blood infusions, and time course of severely-injured hemorrhagic shock patients in the EMS and ED settings from the diaspirin cross-linked hemoglobin (DCLHb) clinical trial.
METHODS: Data were analyzed from 17 US trauma centers gathered during a randomized, controlled, single-blinded efficacy trial of a hemoglobin solution (DCLHb) as add-on therapy versus standard therapy.
RESULTS: Among the 98 randomized patients, the mean EMS Glasgow Coma Scale (GCS) was 10.6 (SD = 5.0), the mean EMS revised trauma score (RTS) was 6.3 (SD = 1.9), and the mean injury severity score (ISS) was 31 (SD = 17). Upon arrival to the ED, the GCS was 20% lower (7.8 (SD = 5.3) vs 9.7 (SD = 6.3)) and the RTS was 12% lower (5.3 (SD = 2.0) vs 6.0 (SD = 2.1)) than EMS values in blunt trauma patients (P < .001). By ED disposition, 80% of patients (78/98) were intubated. Rapid sequence intubation (RSI) was utilized in 77% (60/78), most often utilizing succinylcholine (65%) and midazolam (50%). The mean crystalloid volume infused was 4.2 L (SD = 3.4 L), 80% of which was infused within the ED. Emergency department blood transfusion occurred in 62% of patients, with an average transfused volume of 1.2 L (SD = 2.0 L). Blunt trauma patients received 2.1 times more total fluids (7.4 L vs 3.5 L, < .001) and 2.4 times more blood (2.4 L vs 1.0 L, P < .001). The mean time of patients taken from injury site to operating room (OR) was 113 minutes (SD = 87 minutes). Twenty-one (30%) of the 70 patients taken to the OR from the ED were sent within 60 minutes of the estimated injury time. Penetrating trauma patients were taken to the OR 52% sooner than blunt trauma patients (72 minutes vs 149 minutes, P < .001).
CONCLUSION: Both GCS and RTS decreased prior to ED arrival in blunt trauma patients. Intubation was performed using RSI, and crystalloid infusion of three times the estimated blood loss volume (L) and blood transfusion of the estimated blood loss volume (L) were provided in the EMS and ED settings. Surgical intervention for these trauma patients most often occurred more than one hour from the time of injury. Penetrating trauma patients received surgical intervention more rapidly than those with a blunt trauma mechanism.

Entities:  

Keywords:  DCLHb diaspirin cross-linked hemoglobin; ED emergency department; EMS Emergency Medical Services; ETI endotracheal intubation; GCS Glasgow Coma Scale; HR heart rate; ISS injury severity score; IV intravenous; MOI mechanism of injury; OR operating room; PRBC packed red blood cell; RR respiratory rate; RSI rapid sequence intubation; RTS revised trauma score; SBC systolic blood pressure; T-RTS triage revised trauma score; TBI traumatic brain injury; wounds and injuries

Mesh:

Substances:

Year:  2014        PMID: 25499006     DOI: 10.1017/S1049023X14001174

Source DB:  PubMed          Journal:  Prehosp Disaster Med        ISSN: 1049-023X            Impact factor:   2.040


  3 in total

1.  Prehospital volume therapy as an independent risk factor after trauma.

Authors:  Bjoern Hussmann; Matthias Heuer; Rolf Lefering; Alexander Touma; Carsten Schoeneberg; Judith Keitel; Sven Lendemans
Journal:  Biomed Res Int       Date:  2015-04-09       Impact factor: 3.411

Review 2.  Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?

Authors:  Abdu I Alayash
Journal:  Biomolecules       Date:  2017-01-04

3.  Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.

Authors:  Abdu I Alayash
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.